These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2932659)

  • 41. Stimulation of adenylate cyclase in rat striatum by pergolide: influence of GTP.
    Rosenfeld MR; Makman MH; Goldstein M
    Eur J Pharmacol; 1980 Nov; 68(1):65-8. PubMed ID: 7449835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D2 dopamine receptor activation inhibits basal and forskolin-evoked acetylcholine release from dissociated striatal cholinergic interneurons.
    Login IS
    Brain Res; 1997 Feb; 749(1):147-51. PubMed ID: 9070641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
    Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
    Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscarinic agonist inhibition of rat striatal adenylate cyclase is enhanced by dopamine stimulation.
    DeLapp NW; Eckols K; Shannon HE
    Life Sci; 1996; 59(7):565-72. PubMed ID: 8761345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
    Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
    Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
    Olianas MC; Onali P
    Neurosci Lett; 1987 Aug; 78(3):349-54. PubMed ID: 2819791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective inhibition by pentobarbital of forskolin-stimulated adenylate cyclase activity in rat brain.
    Dan'ura T; Kurokawa T; Yamashita A; Ishibashi S
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3142-4. PubMed ID: 2632062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy.
    Andersen PH; Jansen JA
    Eur J Pharmacol; 1990 Jun; 188(6):335-47. PubMed ID: 1973652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phorbol esters increase GTP-dependent adenylate cyclase activity in rat brain striatal membranes.
    Olianas MC; Onali P
    J Neurochem; 1986 Sep; 47(3):890-7. PubMed ID: 3734803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.
    Hatta Y; Hatta S; Saito T
    Psychopharmacology (Berl); 1993; 110(4):383-9. PubMed ID: 7870906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antagonism of l-stepholidine on D2 receptor-mediated inhibition of synaptosomal adenylate cyclase in rat corpus striatum.
    Hu G; Hu Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):104-10. PubMed ID: 1598823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PK 11195 blockade of benzodiazepine-induced inhibition of forskolin-stimulated adenylate cyclase activity in the striatum.
    Tenn CC; Neu JM; Niles LP
    Br J Pharmacol; 1996 Sep; 119(2):223-8. PubMed ID: 8886401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation.
    Quik M; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):141-5. PubMed ID: 212684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced adenylate cyclase activity in neonatally dopamine lesioned rats is related to increased Gs-protein coupling.
    Cowburn R; Young D; Luthman J
    Eur J Pharmacol; 1991 Jul; 207(3):271-4. PubMed ID: 1654267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat.
    Pifl C; Reither H; Hornykiewicz O
    Brain Res; 1992 Feb; 572(1-2):87-93. PubMed ID: 1535275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.